title: Extended remission of a recurrent median nerve malignant peripheral nerve sheath tumor after multimodal treatment. Case report.
abstract: Malignant peripheral nerve sheath tumors (MPNSTs) are difficult to control despite aggressive treatment. In this report the authors describe the treatment and follow-up review of a patient with neurofibromatosis Type I who harbored a recurrent median nerve MPNST. The man underwent preoperative intraarterial and intravenous chemotherapy followed by additional surgery for gross-total removal and postoperative radiotherapy. Two courses of preoperative intraarterial cisplatin and intravenous Adriamycin produced significant tumor shrinkage. Gross-total removal of the remaining tumor without amputation of the arm was followed by fractionated radiotherapy (total minimum tumor dose 6485 cGy, maximal dose 6575 cGy). The patient is alive 9.5 years after treatment without evidence of tumor recurrence and with only focal median nerve functional deficits. A review of the patient's treatment is warranted to provide a description of a regimen that may be useful in the treatment of similar patients in the future.
authors.affiliation: Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida 33136, USA. hlandy@med.miami.edu
authors.forename: Howard
authors.initials: H
authors.lastname: Landy
authors.forename: Lynn
authors.initials: L
authors.lastname: Feun
authors.forename: Arnold
authors.initials: A
authors.lastname: Markoe
authors.forename: Sherri
authors.initials: S
authors.lastname: Patchen
authors.forename: Joy
authors.initials: J
authors.lastname: Bruce
authors.forename: Justin
authors.initials: J
authors.lastname: Marcus
authors.forename: Allan
authors.initials: A
authors.lastname: Levi
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D018317:Nerve Sheath Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D009456:Neurofibromatosis 1 / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D004317:Doxorubicin; D002945:Cisplatin